Welford, Abigail F <br/><br/>
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice.  [electronic resource] 

 -  The Journal of clinical investigation  May 2011 
 - 1969-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI44562  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Cell Separation<br/>Chemokine CXCL12--metabolism<br/>Female<br/>Flow Cytometry<br/>Macrophages--metabolism<br/>Mammary Neoplasms, Animal<br/>Mice<br/>Mice, Transgenic<br/>Necrosis--pathology<br/>Neoplasm Transplantation<br/>Receptor Protein-Tyrosine Kinases--metabolism<br/>Receptor, TIE-2<br/>Receptors, CXCR4--metabolism<br/>Stilbenes--pharmacology